Cancer Investigation

Papers
(The TQCC of Cancer Investigation is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies75
Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective Analysis65
Artificial Intelligence in Cancer Clinical Research: V. What We Have Learned About Human Intelligence from Artificial Intelligence23
Racial Diversity and Reporting in United States Food and Drug Administration Registration Trials for Thoracic Malignancies from 2006 to 202020
Adverse Events Induced by Nivolumab Plus Ipilimumab vs. Nivolumab Monotherapy among Cancer Patients: A Systematic Review and Meta-Analysis20
Effect of Androgen–Androgen Receptor Directed Therapy on COVID-19 Outcome in Prostate Cancer Patients18
PARP Inhibitors Rising as an Epoch-Making Strategy in First-Line Maintenance Therapy of Ovarian Cancer: A Systematic Review and Meta-Analysis17
Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit17
Clinical Analysis of the Efficacy and Safety of Different Neoadjuvant Strategies in the Treatment of Locally Advanced Rectal Cancer15
COVID-19 Outbreak Impact on Cancer Multidisciplinary Team Meetings. A Multicenter French Experience15
Clinical validation of a ctDNA-Based Assay for Multi-Cancer Detection: An Interim Report from a Vietnamese Longitudinal Prospective Cohort Study of 2795 Participants15
Tumor Properties Mediate the Relationship between Peripheral Blood Monocytes and Tumor-Associated Macrophages in Breast Cancer13
Perception, Cognition and Thought: Part I Nature, Evolution and Development of Conceptual and Symbolic Processes12
Development and Validation of a Nomogram for Prognosis Prediction in Patients with Synchronous Primary Thyroid and Breast Cancer Based on SEER Database12
A Nomogram for Predicting Survival in Advanced Non-Small-Cell Lung Carcinoma Patients: A Population-Based Study12
The Democratization of Hematology-Oncology Medical Education during the COVID-19 Pandemic11
Current Use and Limitations of Cultured High-Grade Meningioma Cells in Neuro-Oncological Research – In Response to: “Caution Using Meningioma Cell Lines as Tumor Models”11
The Relationship Between Body Image and Meaning of Life Among Women with Breast Cancer in Kerman, Iran10
Perineural Invasion as a Prognostic Factor in Laryngeal Squamous Cell Cancer: A Matched-Pair Survival Analysis10
Decision Aids for Decision Making about Locally Advance Breast Cancer: A Systematic Review10
Clinical Validation of Local Versus Commercial Genomic Testing in Cancer: A Comparison of Tissue and Plasma Concordance10
Efficacy and Safety of Additional S-1 Chemotherapy to S-1 Plus Oxaliplatin Regimen Chemotherapy for Stage III Gastric Carcinoma after Radical Resection10
A Mechanistic Review of Methotrexate and Celecoxib as a Potential Metronomic Chemotherapy for Oral Squamous Cell Carcinoma10
Long Non-Coding RNA and Chemoresistance in Bladder Cancer – A Mini Review10
Gene Expression Analysis of Early Stage Changes in Pancreatic Cancer by Kras G12D Transfer in Pancreatic Progenitor-10
Correction9
Correction8
Determinants of Post-Traumatic Growth and Quality of Life in Ghanaian Breast Cancer Survivors8
Elevated Expression of LGR5 and WNT Signaling Factors in Neuroblastoma Cells With Acquired Drug Resistance8
The Clinical Significance and Utility of HPV-DNA Testing in Korean Women with Atypical Glandular Cells in Cervical Pap Tests: An Analysis of 311 Cases at a Single Institution7
Dynamic Changes of Peripheral NK Cells Predict Outcome in Patients with PD-L1 Positive Non-small-cell Lung Cancer Undergoing Immune Checkpoint Inhibitors as Second-line Therapy7
A Review on Emerging Techniques for Diagnosis of Colorectal Cancer7
Comparative Evaluation of Serum Irisin Levels in Cancer Patients and Healthy Individuals: A Systematic Review and Meta-Analysis of Diagnostic Evidence7
The Prevalence of Polypharmacy and Potential Drug–Drug Interactions among Iranian Cancer Patients: Which Patients were at Risk?7
Approaches for Head and Neck Cancer Research – Current Status and the Way Forward7
Webinar as an Informational Resource on Trastuzumab Biosimilars: Planning, Promotion, Execution, and Evaluation7
Assessing Chemotherapy-Induced Peripheral Neuropathy in Postmenopausal Breast Cancer Patients Using Vibration Perception Threshold7
Sepsis-related outcomes of patients with Philadelphia-negative myeloproliferative neoplasms7
Integrative Analysis Developing and Validating Potential Candidate Biomarkers for Cancer Stemness Features of Pan-Renal Cell Carcinoma7
p53 Missense Mutation is Associated with Immune Cell PD-L1 Expression in Triple-Negative Breast Cancer6
Evaluation of High-Dimensional Data Classification for Skin Malignancy Detection Using DL-Based Techniques6
Human Mycobiota and Its Role in Cancer Progression, Diagnostics and Therapeutics: A Link Lesser-Known6
Analytical and Clinical Validation of a Target-Enhanced Whole Genome Sequencing-Based Comprehensive Genomic Profiling Test6
The Hiroshima A-Bomb Black Rain and the Lifespan Study; A Resolution of the Enigma6
Update on Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 2000-20186
Fusobacterium Detected in Barrett’s Esophagus and Esophageal Adenocarcinoma Tissues6
Rare Association between Sarcoidosis and Smoldering Multiple Myeloma: A Case Report6
Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma6
Tumoral Overexpression of Hepcidin is Associated with Poor Prognosis of Patients with Clear Cell Renal Cell Carcinoma6
Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms6
The Nature, Origin and Evolution of Life: Part II The Origin of Life6
Signaling Pathways Involved in 5-FU Drug Resistance in Cancer6
Curcumin Enhances the Efficacy of Docetaxel by Promoting Anti-Tumor Immune Response in Head and Neck Squamous Cell Carcinoma6
Neoadjuvant Therapy and Axillary Lymph Node Status in HER2-Positive Breast Cancer6
An Overview of Cancer Biology, Pathophysiological Development and It’s Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy6
Akt Phosphorylation Orchestrates T11TS Mediated Cell Cycle Arrest in Glioma Cells6
Capecitabine-Enhanced Brachytherapy in Locally Advanced Cervical Cancer: A Phase II Non-Randomized Trial on Safety and Efficacy6
Recurrence Patterns and Clinical Management after a Positive Sentinel Node Biopsy in Melanoma Patients5
Metagenomic Analysis of Biliary Microbial Flora in Patients with Gallbladder Cancer or Gallstones-Associated Chronic Cholecystitis5
Real World Presentation and Treatment Outcomes with a Predominant Induction Chemotherapy Based Approach in Nasopharyngeal Carcinoma: A Sixteen Year Report from a Teaching Hospital in India5
Flamingo Search Sailfish Optimizer Based SqueezeNet for Detection of Breast Cancer Using MRI Images5
Telomere Shortening of Barrett’s Esophagus and Esophageal Adenocarcinoma in Japanese Patients5
Immunomodulation of the Breast Cancer Microenvironment by Tumor-Derived Exosomes: Implications for Immunotherapy5
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: Correspondence5
Surgical Trauma-induced CCL2 Upregulation Mediates Lung Cancer Progression by Promoting Treg Recruitment in Mice and Patients5
Engineering Novel CD19/CD22 Dual-Target CAR-T Cells for Improved Anti-Tumor Activity5
Efficacy and Safety of First-Line Platinum-Based Doublet Chemotherapy in Advanced Primary Pulmonary Salivary Gland Tumors (PSGTs)5
Utility Values in Colorectal Cancer Patients Treated with Chemotherapy4
Postoperative Radiotherapy for Cutaneous Melanoma in Patients at High Risk of Local-Regional Recurrence after Surgery Alone4
Outcomes of Cancer Patients with COVID-19: The Virginia Commonwealth University Experience4
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study4
Platinum-Pemetrexed Chemotherapy for Recurrent Ovarian Cancer (ROC): A Single Center Experience4
Evidence-Based Medicine and Complementary and Alternative Medicine – Attitudes and Knowledge of German Medical Students4
Does Aspirin Use Reduce the Risk for Ovarian Cancer?4
Beyond the Horizon: A Cutting-Edge Review of the Latest Checkpoint Inhibitors in Cancer Treatment4
Modified Le-Net Model with Multiple Image Features for Skin Cancer Detection4
Trends and Projections of Stomach Cancer Incidence in Hong Kong: A Population-Based Study4
Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions4
A Systematic Review of the Treatment Outcomes among Prostate Cancer Patients in Africa4
Glucose Metabolism and Glucose Transporters in Head and Neck Squamous Cell Carcinoma4
Comorbidity in Small Cell Lung Cancer: Prognostic Impacts of Hypertension/Coronary Artery Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease4
Increased Risk of Hyperglycemia in Advanced Urothelial Cancer Patients Treated with Enfortumab Vedotin: A Systematic Review and Meta-Analysis4
Magnetic Resonance Imaging Guided Prostate Biopsy in Patients with ≥ One Negative Systematic Transrectal Ultrasound-Guided Biopsy: A Systemic Review and Meta-Analysis4
Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls4
The Sledgehammer in Precision Medicine: Dexamethasone and Immunotherapeutic Treatment of Glioma4
A Comprehensive Insight into Apoptosis: Molecular Mechanisms, Signaling Pathways, and Modulating Therapeutics4
Fear of Cancer Recurrence and COVID-19 Anxiety Among Cancer Survivors: A Cross-Sectional Study in Southeast Iran4
Gender, Bladder Cancer Healthcare and Burden of COVID-194
TTYH3 Promotes Cervical Cancer Progression by Activating the Wnt/ β -Catenin Signaling Pathway4
0.061312913894653